((2R*,3R*)-2-(2,5-Dimethoxyphenyl)-3-((R*)-tetrahydrofuran-
2-yl)-tetrahydrofuran (minor product 5g; Table 3; Entry g). Yield,
30 mg, 22%; Liquid; H NMR (400 MHz, CDCl3): d 7.04–7.00
125.9, 125.6, 113.4, 81.3, 68.8, 55.2, 39.8, 39.5, 31.4, 29.2, 16.7; IR
(KBr): n 2931, 2837, 1509, 1246, 1090, 1023, 742 cm-1; ESI-MS:
m/z 317 (M + Na)+; HRMS calculated for C20H23O2 (M + H):
295.1698, found 295.1690.
1
(m, 1H), 6.72–6.65 (m, 2H), 5.02 (d, J = 5.9 Hz, 1H), 4.18–4.09
(m, 1H), 3.88–3.79 (m, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 3.72–3.64
(m, 1H), 3.49–3.40 (m, 1H), 3.34–3.24 (m, 1H), 2.57–2.44 (m,
1H), 2.34–2.21 (m, 1H), 2.20–2.07 (m, 1H), 1.77–1.52 (m, 2H),
1.12–0.95 (m, 2H);13C NMR (75 MHz, CDCl3): d 153.5, 150.5,
129.5, 112.9, 112.7, 110.5, 78.5, 77.2, 67.0, 66.8, 55.8, 55.6, 47.1,
30.2, 29.3, 26.0; IR (neat): n 2944, 2869, 1497, 1217, 1058, 806
cm-1; ESI-MS: m/z 279 (M + H)+; HRMS (ESI) calculated for
C16H23O4 (M + H)+: 279.3514, found 279.3507.
(4R*,4aR*,10bS*)-4-(Benzo[d][1,3]dioxol-5-yl)-2,4,4a,5,6,10b-
hexahydro-1H-benzo[f ]isochro◦mene (7c; Table 4; Entry c). Yield,
126 mg, 82%; Solid, mp 84–86 C; 1H NMR (300 MHz, CDCl3): d
7.24–7.16 (m, 1H), 7.15–6.96 (m, 3H), 6.84–80 (m, 1H), 6.78–6.69
(m, 2H), 5.93 (s, 2H), 4.26 (ddd, J = 11.5, 4.3 and 1.3 Hz, 1H),
3.97 (d, J = 9.6 Hz, 1H), 3.76 (dt, J = 12.3 and 2.3 Hz, 1H), 2.82–
2.60 (m, 3H), 2.39–2.26 (m, 1H), 1.83–1.66 (m, 1H), 1.65–1.27 (m,
3H); 13C NMR (75 MHz, CDCl3): d 147.7, 147.1, 138.9, 136.4,
134.7, 128.9, 125.9, 125.7, 124.7, 121.1, 107.8, 107.5, 100.9, 85.2,
68.5, 44.6, 41.4, 30.7, 28.7, 24.6; IR (KBr): n 2919, 2846, 1490,
1443, 1248, 1092, 1038, 744 cm-1; MS (APCI): m/z 309 (M +
H)+; HRMS (APCI) calculated for C20H21O3 (M + H)+: 309.1491,
found 309.1502.
Typical procedure for the intramolecular Prins/Friedel–Crafts
cyclization via C–H activation
˚
To a 25 mL two neck round bottom flask containing dried 4 A
molecular sieves (400 mg) was added a solution of homoallylic
ether substrate 6 (0.5 mmol) in anhydrous dichloromethane
(10 mL) under an argon atmosphere. Then DDQ (1.1 equiv.)
and SnCl4 (1.1 equiv., 1 M in DCM) were added sequentially
at -10 ◦C. The resulting mixture was stirred at room temperature
for the specified time (Table 4). After completion of the reaction
as indicated by TLC, it was quenched with saturated aqueous
NaHCO3 solution and then extracted with Et2O (2 ¥ 20 mL).
The organic extracts were washed with brine (2 ¥ 5 mL), dried
over anhydrous Na2SO4 and concentrated in vacuo. The resulting
crude product was purified by column chromatography (silica gel,
100–200 mesh) using a gradient mixture of ethyl acetate/hexane
to afford pure product 7 (Table 4).
(4R*,4aR*,10bS*)-8-Methoxy-4-(3-methoxyphenyl)-2,4,4a,5,6,
10b-hexahydro-1H-benzo[f ]isochromene (7d; Table 4; Entry d).
The reaction afforded a 3 : 1 mixture of para-/ortho-substituted
products. The two regioisomers could be easily separated by silica
gel column chromatography. Y◦ield of major regioisomer, 94 mg,
58%; White solid, mp 108–110 C; 1H NMR (300 MHz, CDCl3):
d 7.24–7.17 (m, 1H), 7.11 (d, J = 8.3 Hz, 1H), 6.90–6.75 (m,
3H), 6.66 (dd, J = 8.3 and 2.3 Hz, 1H), 6.52 (d, J = 2.3 Hz, 1H),
4.28 (ddd, J = 11.3, 4.5 and 1.5 Hz, 1H), 4.02 (d, J = 9.8 Hz,
1H), 3.83–3.72 (m, 7H), 2.78–2.58 (m, 3H), 2.37–2.26 (m, 1H),
1.84–1.67 (m, 1H), 1.66–1.23 (m, 3H); 13C NMR (75 MHz,
CDCl3): d 159.6, 157.7, 142.3, 137.8, 131.2, 129.3, 125.8, 120.0,
113.6, 113.5, 112.7, 111.7, 85.4, 68.5, 55.2, 44.9, 41.0, 30.9, 29.0,
24.6; IR (KBr): n 2942, 2843, 1588, 1455, 1259, 1084, 1040, 786
cm-1; MS (APCI): m/z 325 (M + H)+; HRMS (APCI) calculated
for C21H25O3 (M + H)+: 325.1804, found 325.1806.
(4R*,4aR*,10bS*)-4-(4-Methoxyphenyl)-2,4,4a,5,6,10b-hexa-
hydro-1H-benzo[f ]isochromene (7a; Table 4; Entry a). Yield,
1
115 mg, 78%; Semi-solid; H NMR (600 MHz, CDCl3): d 7.30–
7.26 (m, 3H), 7.20–7.16 (m, 1H), 7.15–7.12 (m, 1H), 7.08–7.04 (m,
1H), 6.91–6.87 (m, 2H), 4.31 (ddd, J = 11.5, 4.5 and 1.5 Hz, 1H),
4.06 (d, J = 9.7 Hz, 1H), 3.85–3.79 (m, 4H), 2.81–2.68 (m, 3H),
2.36 (tdd, J = 12.5, 4.5 and 2.0 Hz, 1H), 1.79 (dq, J = 12.5 and
4.5 Hz, 1H), 1.67 (dddd, J = 12.6, 11.2, 9.7 and 3.1 Hz, 1H), 1.45
(tdd, J = 12.6, 6.7 and 3.1 Hz, 1H), 1.36 (dtd, J = 12.6, 11.2 and
6.7 Hz, 1H); 13C NMR (75 MHz, CDCl3): d 159.2, 139.0, 136.5,
133.0, 128.9, 128.6, 125.9, 125.7, 124.7, 113.7, 85.0, 68.5, 55.2,
44.6, 41.5, 30.7, 28.7, 24.6; IR (KBr): n 2922, 2840, 1513, 1249,
1092, 828, 743 cm-1; ESI-MS: m/z 295 (M + H); HRMS calculated
for C20H23O2 (M + H)+: 295.1698, found 295.1699.
(4R*,4aS*,10bS*)-8-Methoxy-4-phenyl-2,4,4a,5,6,10b-hexa-
hydro-1H-benzo[f ]isochromene (7e; Table 4; Entry e). The reac-
tion afforded a 3 : 1 mixture of para-/ortho-substituted products.
The two regioisomers could be easily separated by silica gel column
chromatography. Yield of major regioisomer, 81 mg, 55%; Semi-
solid; 1H NMR (300 MHz, CDCl3): d 7.35–7.13 (m, 5H), 6.98–6.89
(m, 1H), 6.69–6.56 (m, 1H), 6.53–6.46 (m, 1H), 4.64 (br s, 1H),
4.22–4.10 (m, 1H), 3.83–3.61 (m, 4H), 3.07–2.95 (m, 1H), 2.78–
2.48 (m, 2H), 2.12–1.97 (m, 1H), 1.96–1.53 (m, 3H), 1.32–1.17 (m,
1H); 13C NMR (75 MHz, CDCl3): d 157.6, 141.3, 137.2, 133.2,
129.4, 128.0, 126.6, 125.5, 113.2, 112.2, 81.7, 68.7, 55.1, 39.9, 38.8,
31.5, 29.5, 16.6; IR (KBr): n 2932, 2845, 1500, 1265, 1097, 703
cm-1; MS (APCI): m/z 295 (M + H); HRMS (APCI) calculated
for C20H23O2 (M + H): 295.1698, found 295.1705.
(4R*,4aS*,10bS*)-4-(4-Methoxyphenyl)-2,4,4a,5,6,10b-hexa-
hydro-1H-benzo[f ]isochromene (7b; Table 4; Entry b). Crystals
for XRD were obtained by dissolving compound in 4–5 mL
ethanol, followed by slow evaporation of◦solvent over 4 days. Yield,
118 mg, 80%; White solid, mp 118–120 C; 1H NMR (600 MHz,
CDCl3): d 7.25–7.22 (m, 2H), 7.16–7.09 (m, 3H), 7.08–7.04 (m,
1H), 6.92–6.88 (m, 2H), 4.68 (d, J = 2.8 Hz, 1H), 4.21 (ddd, J =
11.5, 4.7 and 1.2 Hz, 1H), 3.81 (s, 3H), 3.76 (ddd, J = 12.7, 11.5
and 2.3 Hz, 1H), 3.12 (td, J = 12.8 and 4.7 Hz, 1H), 2.78 (ddd, J =
17.0, 5.8 and 1.7 Hz, 1H), 2.62 (ddd, J = 17.0, 12.8 and 6.3 Hz,
1H), 2.06 (tdd, J = 13.0, 4.7 and 2.8 Hz, 1H), 1.92 (dq, J = 12.8
and 4.7 Hz, 1H), 1.81 (dq, J = 13.0 and 5.8 Hz, 1H), 1.73–1.67 (m,
1H), 1.35 (tddd, J = 13.0, 6.3, 2.8 and 1.7 Hz, 1H); 13C NMR (75
MHz, CDCl3): d 158.3, 140.9, 136.1, 133.5, 129.0, 128.6, 126.6,
(4R*,4aR*,10bS*)-9-Methyl-4-(naphthalen-2-yl)-2,4,4a,5,6,
10b-hexahydro-1H-benzo[f ]isochromene ◦(7f; Table 4; Entry f).
Yield, 123 mg, 75%; Solid, mp 102–104 C; 1H NMR (300 MHz,
CDCl3): d 7.84–7.72 (m, 4H), 7.50–7.38 (m, 3H), 7.06–7.02 (m,
1H), 6.92–6.84 (m, 2H), 4.34 (ddd, J = 11.3, 4.5 and 1.5 Hz, 1H),
4.23 (d, J = 9.8 Hz, 1H), 3.84 (dt, J = 12.1 and 2.3 Hz, 1H), 2.80–
2.59 (m, 3H), 2.45–2.35 (m, 1H), 2.32 (s, 1H), 1.92–1.66 (m, 2H),
1.50–1.31 (m, 2H); 13C NMR (75 MHz, CDCl3): d 138.7, 138.3,
135.1, 133.3, 133.2, 128.9, 128.1, 128.0, 127.6, 126.8, 126.7, 126.0,
125.8, 125.4, 125.2, 85.7, 68.7, 44.8, 41.6, 30.9, 28.4, 24.8, 21.2; IR
This journal is
The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 1349–1358 | 1357
©